skip to main content
Main Site Navigation
Top of main content
Redefining HealthcareAround You.
Filming this video took place prior to COVID-19 pandemic
WATCH VIDEO
AUDIO DESCRIPTIONS

Treated Conditions

AVM (Arteriovenous Malformation)
Blurry Vision
Carotid and Vertebral Artery Dissection

Research and Clinical Trials

Neuroscience research at Carle represents the intersection of technology, medicine, science, and care. By providing our patients with the opportunity to participate in translational and clinical studies we hope to engage them in not only their own care but also the future of medicine. Our researchers and providers strive to advance diagnostic capabilities, understand causes and effects, and improve patient quality of life. Our research department supports clinicians and faculty alike in their efforts to provide excellent care and perform extraordinary science.

By participating in research studies, Carle Neuroscience Institute seeks to create a better understanding of the structure and function of neurological systems allowing us to advance clinical care possible and ultimately improve the overall promotion of human health and quality of life.

Carle Neuroscience Institute Research is known for demonstrating improved clinical outcomes for patients through research efforts that focus on the development of predictive analysis, novel diagnostics, and comparative efficacy.

Effects of Alcohol After Bariatric Surgery (RBA)

The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.

Fecal Microbiota Transplant National Registry (FMT)

This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout North America. Information on FMT methodology employed (e.g., screening of donor and recipient, preparation, FMT delivery) will be collected from each site. The indication for FMT as well as baseline information on recipient will also be collected. Following FMT, patients will be followed at regular intervals up to 10 years post FMT. This will include follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year, and 2 years after FMT as well as direct communication with patients at least annually up to 10 years after FMT. Follow-up information collected will be designed to assess potential short-term and long-term safety and effectiveness.

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

SEE MORE CLINICAL TRIALS

Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.

MEET OUR TEAM

Giving

Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for Carle patients and their loved ones. With your support, we’ll advance the care of neurological diseases and meet the needs of the 
ever-expanding Carle Neuroscience Institute.

DONATE NOW GIVING AT CARLE

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

    • GL Accredited Hospital
    • Healthgrades logo
    • Get with the guidelines - 2018 gold plus certified